AZD9592 Clinical Trials
2 recruitingBiologic
Phase 11Early Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1
First in Human Study of AZD9592 in Solid Tumors
Advanced Solid Tumours
AstraZeneca403 enrolled50 locationsNCT05647122
Recruiting
Early Phase 1
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC
Head and Neck Squamous Cell Carcinoma
Presage Biosciences15 enrolled7 locationsNCT06366451